Poster

Opioid Antagonists: Clinical Utility, Pharmacology, and Safety and Tolerability

Pharmacology, clinical uses, and safety/tolerability of FDA-approved opioid antagonists are reviewed. Opioid antagonists treat opioid overdose, alcohol/opioid use disorder, and opioid-ind...

Mark Todtenkopf , PhD;

10/26/2023

Outcomes From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia

OASIS was an observational study that evaluated real-world outcomes of atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Overall, CGI-S scores at basel...

Peter J. Weiden , MD, PhD;

10/26/2023

Patient Perspective on Idiopathic Hypersomnia: Impact on Quality of Life and Satisfaction With the Diagnostic Process and Management

This study assessed symptoms, impact, diagnosis, and management of idiopathic hypersomnia in US patients surveyed online. Most respondents reported they had been misdiagnosed before recei...

Marisa Whalen , PharmD;

10/26/2023

Patient Perspectives of Meaningful Change in Major Depressive Disorder

Findings from qualitative interviews with 19 US adult patients with major depressive disorder (MDD) highlighted the episodic and heterogeneous nature of MDD, as well as the importance of ...

Robin Tan , PhD;

10/26/2023

Patient Perspectives on Major Depressive Disorder Care to Inform Patient-Centered Approaches

To better understand patients’ experiences and perceptions of their major depressive disorder (MDD) care, we designed a 21-item survey to capture patient perceptions of their MDD symptoms...

Laura Simone , PhD;

10/26/2023

Patient Preferences and Nocturnal Experiences With Oxybate Therapy for Narcolepsy: RESTORE Study Interim Analysis

RESTORE (NCT04451668), an ongoing open-label/switch study evaluating the safety/tolerability of once-nightly sodium oxybate (ON-SXB), included 2 questionnaires administered to participant...

Asim Roy , MD;

10/26/2023

Mental Health Comorbidities Among Patients With Chronic Medical Conditions and Alcohol Use Disorder

The aim of this retrospective cohort study was to describe mental health comorbidities among patients with selected ambulatory-care sensitive conditions and comorbid alcohol use disorder ...

Lauren Strand , PhD, MS;

10/26/2023

Mobile Technology-Supported Shared Decision-Making and Goal Setting for Management of Depression in Primary Care

Mobile-based apps have potential to assist clinicians and patients in the shared decision-making (SDM) process for management of major depressive disorder (MDD). Primary Care Path is a pr...

Christina M. Hester , PhD, MPH;

10/26/2023

Multiple Factors Underlying Diagnostic Etiology of Psychosis: A Case Report.

27 year old male with history of HIV infection and substance abuse disorder arrived at the ER presenting aggressive behavior, errors of judgment and conduct, ego dystonic complex, auditor...

Patricio Mendoza Galvez , MD;

10/26/2023

No Signs of MDMA-Related Histopathological Changes to CNS in Rats and Dogs in A 28-Day Repeated Oral Dose Neurotoxicity Study

3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy is being investigated as a potential treatment option for patients with posttraumatic stress disorder (PTSD). Previous animal MDM...

Berra Yazar-Klosinski , PhD;

10/26/2023